BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7561031)

  • 1. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
    Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
    J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
    Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
    J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles.
    Law CL; Torres RM; Sundberg HA; Parkhouse RM; Brannan CI; Copeland NG; Jenkins NA; Clark EA
    J Immunol; 1993 Jul; 151(1):175-87. PubMed ID: 8100843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the expression and gene promoter of CD22 in murine B cells.
    Andersson KB; Draves KE; Magaletti DM; Fujioka S; Holmes KL; Law CL; Clark EA
    Eur J Immunol; 1996 Dec; 26(12):3170-8. PubMed ID: 8977319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
    Engel P; Wagner N; Miller AS; Tedder TF
    J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion.
    Stamenkovic I; Seed B
    Nature; 1990 May; 345(6270):74-7. PubMed ID: 1691828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic structure and chromosomal mapping of the human CD22 gene.
    Wilson GL; Najfeld V; Kozlow E; Menniger J; Ward D; Kehrl JH
    J Immunol; 1993 Jun; 150(11):5013-24. PubMed ID: 8496602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule.
    Torres RM; Law CL; Santos-Argumedo L; Kirkham PA; Grabstein K; Parkhouse RM; Clark EA
    J Immunol; 1992 Oct; 149(8):2641-9. PubMed ID: 1401903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD22 regulates thymus-independent responses and the lifespan of B cells.
    Otipoby KL; Andersson KB; Draves KE; Klaus SJ; Farr AG; Kerner JD; Perlmutter RM; Law CL; Clark EA
    Nature; 1996 Dec 19-26; 384(6610):634-7. PubMed ID: 8967951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for mucosal vascular addressin binding to its lymphocyte receptor alpha 4 beta 7. Common themes among integrin-Ig family interactions.
    Briskin MJ; Rott L; Butcher EC
    J Immunol; 1996 Jan; 156(2):719-26. PubMed ID: 8543825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22.
    DiJoseph JF; Popplewell A; Tickle S; Ladyman H; Lawson A; Kunz A; Khandke K; Armellino DC; Boghaert ER; Hamann P; Zinkewich-Peotti K; Stephens S; Weir N; Damle NK
    Cancer Immunol Immunother; 2005 Jan; 54(1):11-24. PubMed ID: 15693135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD40 ligand expressed by human B cells costimulates B cell responses.
    Grammer AC; Bergman MC; Miura Y; Fujita K; Davis LS; Lipsky PE
    J Immunol; 1995 May; 154(10):4996-5010. PubMed ID: 7537298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
    Yousef GM; Ordon MH; Foussias G; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
    Sgroi D; Nocks A; Stamenkovic I
    J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
    Nadler MJ; McLean PA; Neel BG; Wortis HH
    J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CD22 binding to native CD45 and synthetic oligosaccharide.
    Bakker TR; Piperi C; Davies EA; Merwe PA
    Eur J Immunol; 2002 Jul; 32(7):1924-32. PubMed ID: 12115612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.
    Nath D; van der Merwe PA; Kelm S; Bradfield P; Crocker PR
    J Biol Chem; 1995 Nov; 270(44):26184-91. PubMed ID: 7592823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD22.
    Engel P
    J Biol Regul Homeost Agents; 2000; 14(4):295-8. PubMed ID: 11215824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.